Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06121999 · ClinicalTrials.gov registry record · NA
Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults
A NA study, sponsored by Grand Valley State University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT06121999 is a NA study that has completed, run by Grand Valley State University. The registered enrollment target is 24 participants.
The verdict
NCT06121999, a NA study, has completed, sponsored by Grand Valley State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of this randomized control trial study is to compare an acceptance-based weight loss program with an occupational therapy behavioral lifestyle modification intervention in adults with metabolic associated-dysfunction steatotic liver disease (MASLD) and metabolic associated-dysfunction steatohepatitis (MASH). Formerly known as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). The main questions the study aims to answer are: 1. How do the two interventions compare for improving weight loss, health-related quality of life (HRQOL), and FibroScan results. 2. Examine the role of occupational therapy on a multidisciplinary team for the treatment of MASLD and MASH. Participants will meet with an occupational therapist for individual, 60-minute visits for 13 consecutive weeks. Each week participants will be weighed and then engage in a personalized intervention. At the end of the visit participants will be given worksheets and information to work on in-between visits. Researchers will compare the intervention with an acceptance-based behavioral weight loss program that is commonly used for people with obesity and or type 2 diabetes.
Interventions
- BEHAVIORAL Standard of care acceptance-based behavioral weight loss program
- BEHAVIORAL Occupational therapy dietary and lifestyle modifications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-08-17 |
| Est. Completion | 2024-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06121999
The ClinicalTrials.gov registry entry for NCT06121999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Grand Valley State University, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care acceptance-based behavioral weight loss program is the first listed.
NCT06121999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06121999 about?
NCT06121999 is a clinical study titled "Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults". The goal of this randomized control trial study is to compare an acceptance-based weight loss program with an occupational therapy behavioral lifestyle modification intervention in adults with metabolic associated-dysfunction steatotic liver disease (MASLD) and metabolic associated-dysfunction steat...
What is the current status of trial NCT06121999?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-08-17. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT06121999?
The interventions under investigation include: Standard of care acceptance-based behavioral weight loss program (BEHAVIORAL), Occupational therapy dietary and lifestyle modifications (BEHAVIORAL).
Who is sponsoring clinical trial NCT06121999?
This trial is sponsored by Grand Valley State University, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.